Illumina Inc (ILMN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: LABORATORY ANALYTICAL INSTRUMENTS

5200 ILLUMINA WAY SAN DIEGO, CA 92122

Develops and markets next-generation tools for the large-scale analysis of genetic variation and function. The company's tools help researchers gain information that could be used to enhance drug discovery, allow diseases to be detected earlier and permit better choices of drugs for patients.

Data as of 2020-10-17
Market Cap47.759 Billion Shares Outstanding146.36 Million Avg 30-day Volume2.072 Million
P/E Ratio69.2 Dividend Yield EPS4.68
Price/Sales19.541 Price cash flow ratio39.1 Price free cash flow ratio78.6
Book Value31.18 Price to Tangible Book13.49 Alpha0.01
Short Interest Ratio % Short Interest to Float R-squared0.120971
BETA0.892426 52-week High/Low404.2 / 196.78 Stddev0.110194
View SEC Filings from ILMN instead.
Q2 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 22 17 29.41% 9 (0.59%) 10 (0.64%) -10.0%
Funds Holding: 862 803 7.35% 148 (9.65%) 139 (8.89%) 6.47%
13F shares: 133.614 Million 132.208 Million 1.06% 21.034 Million 20.958 Million 0.36%
% Ownership 90.8937 90.0512 0.94% 14.3089 14.2755 0.23%
New Positions: 113 73 54.79% 23 14 64.29%
Increased Positions 338 313 7.99% 58 60 -3.33%
Closed Positions 46 129 -64.34% 12 40 -70.0%
Reduced Positions 286 314 -8.92% 50 52 -3.85%
Total Calls 1.328 Million 1.366 Million -2.78% 456.5 Thousand 537.7 Thousand -15.1%
Total Puts 1.425 Million 1.489 Million -4.26% 549.1 Thousand 572.8 Thousand -4.14%
PUT/CALL Ratio 1.07 1.09 -1.83% 1.2 1.07 12.15%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ILMN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ILMN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

30 Thousand total shares from 32 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FLATLEY JAY T

  • Director
206,933 2020-10-20 20

TOUSI SUSAN H SVP PRODUCT DEVELOPMENT

  • Officer
44,968 2020-10-12 15

GOSWAMI JOYDEEP SVP CORP BUSINESS DEVELOPMENT

  • Officer
2,877 2020-10-05 2

REEVES KATHRYNE GAMBRELL SVP, CHIEF MARKETING OFFICER

  • Officer
1,187 2020-10-05 2

DADSWELL CHARLES SVP & GENERAL COUNSEL

  • Officer
6,157 2020-10-01 13

DESOUZA FRANCIS A PRESIDENT AND CEO

  • Officer
  • Director
68,840 2020-10-01 12

VAN OENE MARK SVP CHIEF COMMERCIAL OFFICER

  • Officer
17,648 2020-09-01 13

RAGUSA ROBERT P SVP, GLOBAL QUALITY & OPS

  • Officer
8,103 2020-08-31 7

MCGINNIS KAREN K VP, CHIEF ACCOUNTING OFFICER

  • Officer
2,350 2020-08-10 5

HOYT AIMEE L SVP, CHIEF PEOPLE OFFICER

  • Officer
3,498 2020-08-04 6

RONAGHI MOSTAFA SVP, ENTREPRENEURIAL DEVLOPMT

  • Officer
86,314 2020-07-27 4

ARAVANIS ALEXANDER SVP, CHIEF TECHNOLOGY OFFICER

  • Officer
3,295 2020-07-06 2

EPSTEIN ROBERT S

  • Director
4,928 2020-05-27 1

ARNOLD FRANCES

  • Director
10,917 2020-05-27 2

SCHILLER PHILIP W

  • Director
10,048 2020-05-27 1

THOMPSON JOHN WENDELL

  • Director
8,049 2020-05-27 1

GUTHART GARY S

  • Director
6,715 2020-05-27 1

SIEGEL SUSAN E

  • Director
5,100 2020-05-27 1

GOTTLIEB SCOTT

  • Director
1,358 2020-05-27 3

SAMAD SAM SVP AND CFO

  • Officer
3,879 2020-05-26 11

DORSA CAROLINE

  • Director
9,005 2020-05-26 1

OSTADAN OMEAD SVP MKTG, PROD & STRAT PLAN

  • Officer
17,172 2020-05-11 6

FEBBO PHILLIP G. SVP CHIEF MEDICAL OFFICER

  • Officer
2,490 2020-04-16 6

HAMPTON MALCOLM GARRET SVP CLINICAL GENOMICS GROUP

  • Officer
6,598 2020-01-09 2

STAPLEY MARC EVP STRATEGY & CORP DEVELOPMT

  • Officer
20,866 2018-12-31 0

EASTHAM KARIN

  • Director
10,838 2018-11-06 0

FLATLEY JAY T

  • Director
400,204 2018-09-12 20

BOWMAN A BLAINE

  • Director
16,814 2018-05-22 0

BOUCHARD MICHEL CHIEF ACCOUNTING OFFICER

  • Officer
9,538 2017-11-06 0

BRADBURY DANIEL

  • Director
15,324 2017-05-25 0

HENRY CHRISTIAN O EVP & CHIEF COMMERCIAL OFFICER

  • Officer
17,531 2017-01-30 0

ORPIN TRISTAN EVP CLINICAL GENOMICS

  • Officer
118,259 2016-11-07 0

WHITFIELD ROY A

  • Director
2,853 2016-08-12 0

BIANCHI PAUL L SR. VP, HUMAN RESOURCES

  • Officer
65,660 2016-04-18 0

WALT DAVID R

  • Director
668,800 2016-04-07 0

NACLERIO NICHOLAS SR VP, CORPORATE DEVELOPMENT

  • Officer
30,020 2016-03-21 0

KLAUSNER RICHARD SR VP, CHIEF MEDICAL OFFICER

  • Officer
22,847 2016-01-29 0

RASTETTER WILLIAM H

  • Director
95,174 2015-12-31 0

HUBER JEFF

  • Director
8,681 2015-12-31 0

MOELLER GERALD

  • Director
17,647 2015-03-31 0

HEATH GREGORY SR VP & GENERAL MANAGER

  • Officer
26,740 2013-12-17 0

LEWIS MARK L SR VP & GENERAL MANAGER

  • Officer
44,837 2013-11-01 0

POSARD MATTHEW L. SR VP & GENERAL MANAGER

  • Officer
30,858 2013-05-30 0

CABOU CHRISTIAN SR VP & GENERAL COUNSEL

  • Officer
46,553 2013-04-23 0

GRINT PAUL C

  • Director
8,365 2013-01-03 0

GOLDSTEIN JACK

  • Director
2,400 2010-05-10 0

MCCOMB JOEL SR VP & GENERAL MANAGER

  • Officer
6,595 2010-01-28 0

STUELPNAGEL JOHN R SR VP AND COO

  • Officer
  • Director
337,836 2008-03-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FLATLEY JAY T - Director

2020-10-22 15:47:13 -0400 2020-10-20 S 1,000 $324.01 d 202,933 direct

FLATLEY JAY T - Director

2020-10-22 15:47:13 -0400 2020-10-20 S 3,000 $320.95 d 203,933 direct

TOUSI SUSAN H - Officer SVP PRODUCT DEVELOPMENT

2020-10-14 16:07:02 -0400 2020-10-12 S 200 $350.00 d 44,968 direct 0.7814 0.7814 2 0.0 1

FLATLEY JAY T - Director

2020-10-08 17:18:53 -0400 2020-10-07 S 1,000 $324.01 d 206,933 direct 3.9169 -3.7547 3.9169 2 -4.5009 5

TOUSI SUSAN H - Officer SVP PRODUCT DEVELOPMENT

2020-10-08 17:21:41 -0400 2020-10-07 S 100 $325.00 d 45,168 direct 3.9169 -3.7547 3.9169 2 -4.5009 5

FLATLEY JAY T - Director

2020-10-07 16:49:24 -0400 2020-10-06 S 3,000 $317.79 d 207,933 direct 1.5759 -2.996 5.5546 3 -2.996 6

GOSWAMI JOYDEEP - Officer SVP CORP BUSINESS DEVELOPMENT

2020-10-07 16:52:17 -0400 2020-10-05 F 115 $316.17 d 2,877 direct 1.5759 -2.996 5.5546 3 -2.996 6

REEVES KATHRYNE GAMBRELL - Officer SVP, CHIEF MARKETING OFFICER

2020-10-07 16:46:33 -0400 2020-10-05 A 2,966 a 2,966 direct

REEVES KATHRYNE GAMBRELL - Officer SVP, CHIEF MARKETING OFFICER

2020-10-07 16:46:33 -0400 2020-10-05 A 1,187 a 1,187 direct 1.5759 -2.996 5.5546 3 -2.996 6

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-10-05 17:14:45 -0400 2020-10-01 S 283 $311.72 d 68,889 direct 2.2252 8.7809 11.0439 5 0.0 1

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-10-05 17:14:45 -0400 2020-10-01 S 595 $308.84 d 69,901 direct 2.2252 8.7809 11.0439 5 0.0 1

DADSWELL CHARLES - Officer SVP & GENERAL COUNSEL

2020-10-05 17:11:19 -0400 2020-10-01 S 121 $312.82 d 6,157 direct 2.2252 8.7809 11.0439 5 0.0 1

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-10-05 17:14:45 -0400 2020-10-01 S 121 $310.55 d 69,172 direct 2.2252 8.7809 11.0439 5 0.0 1

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-10-05 17:14:45 -0400 2020-10-01 S 559 $307.78 d 70,496 direct 2.2252 8.7809 11.0439 5 0.0 1

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-10-05 17:14:45 -0400 2020-10-01 S 49 $312.82 d 68,840 direct 2.2252 8.7809 11.0439 5 0.0 1

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-10-05 17:14:45 -0400 2020-10-01 S 608 $309.89 d 69,293 direct 2.2252 8.7809 11.0439 5 0.0 1

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-10-05 17:14:45 -0400 2020-10-01 S 785 $306.99 d 71,055 direct 2.2252 8.7809 11.0439 5 0.0 1

FLATLEY JAY T - Director

2020-09-17 16:59:40 -0400 2020-09-15 S 4,000 $355.22 d 210,933 direct -8.5854 1.4856 1.4856 6 -9.1337 3

TOUSI SUSAN H - Officer SVP PRODUCT DEVELOPMENT

2020-09-10 16:49:27 -0400 2020-09-09 S 200 $350.00 d 45,268 direct 1.0631 -15.5545 1.0631 2 -15.5545 6

TOUSI SUSAN H - Officer SVP PRODUCT DEVELOPMENT

2020-09-10 16:49:27 -0400 2020-09-08 S 100 $336.00 d 45,468 direct 1.0631 -15.5545 1.0631 2 -15.5545 6

FLATLEY JAY T - Director

2020-09-02 19:35:23 -0400 2020-09-01 S 4,000 $355.35 d 214,933 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-09-02 19:49:34 -0400 2020-09-01 S 300 $354.17 d 72,431 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-09-02 19:49:34 -0400 2020-09-01 S 909 $350.73 d 73,531 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

VAN OENE MARK - Officer SVP CHIEF COMMERCIAL OFFICER

2020-09-02 19:52:47 -0400 2020-09-01 S 585 $355.04 d 17,688 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

DADSWELL CHARLES - Officer SVP & GENERAL COUNSEL

2020-09-02 19:45:27 -0400 2020-09-01 S 1,687 $355.35 d 6,278 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-09-02 19:49:34 -0400 2020-09-01 S 300 $353.01 d 72,731 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-09-02 19:49:34 -0400 2020-09-01 S 400 $349.55 d 74,440 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-09-02 19:49:34 -0400 2020-09-01 S 591 $355.83 d 71,840 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

DESOUZA FRANCIS A - Director - Officer PRESIDENT AND CEO

2020-09-02 19:49:34 -0400 2020-09-01 S 500 $351.76 d 73,031 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

VAN OENE MARK - Officer SVP CHIEF COMMERCIAL OFFICER

2020-09-02 19:52:47 -0400 2020-09-01 S 40 $356.39 d 17,648 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

RAGUSA ROBERT P - Officer SVP, GLOBAL QUALITY & OPS

2020-09-02 19:29:55 -0400 2020-08-31 S 565 $352.93 d 12,538 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

RAGUSA ROBERT P - Officer SVP, GLOBAL QUALITY & OPS

2020-09-02 19:29:55 -0400 2020-08-31 S 1,852 $355.31 d 9,586 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

RAGUSA ROBERT P - Officer SVP, GLOBAL QUALITY & OPS

2020-09-02 19:29:55 -0400 2020-08-31 S 633 $357.63 d 8,103 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

RAGUSA ROBERT P - Officer SVP, GLOBAL QUALITY & OPS

2020-09-02 19:29:55 -0400 2020-08-31 S 1,100 $354.09 d 11,438 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

RAGUSA ROBERT P - Officer SVP, GLOBAL QUALITY & OPS

2020-09-02 19:29:55 -0400 2020-08-31 S 850 $356.00 d 8,736 direct -1.1919 0.9841 -5.8323 2.0576 7 -22.5124 13

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments